The appointment of experienced industry veterans to the Board of Directors is likely to positively impact CAMP4 by strengthening its leadership and strategic direction, particularly in pharmaceutical development and genetic medicine. This move could enhance investor confidence and potentially lead to positive stock performance in the short term.